Antony Burton

Antony Burton currently serves as the Associate Director of Chemical Biology & Proteomics at Dunad Therapeutics, leading proteomics and chemical biology efforts to advance CNS-penetrant, covalent small molecules from hit discovery to development candidate selection since July 2023. Previously, Antony held positions at AstraZeneca as Associate Principal Scientist and Senior Scientist in Chemical Biology & Protein Sciences, delivering critical data for pre-clinical programs and mentoring early-career scientists. Antony’s academic background includes a Damon Runyon Postdoctoral Fellowship at Princeton University, where novel photo proximity labeling methods were developed, and a postdoctoral research role at the University of Bristol focusing on computational protein design and structural biology. Antony earned a Ph.D. from the University of Bristol and completed education at the University of Bath.